BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 682712 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C27H37F3N4O2/c1-20(2)17-33-14-15-36-26-22(18-33)9-7-11-24(26)31-16-25(35)34(13-12-32(3)4)19-21-8-5-6-10-23(21)27(28,29)30/h5-11,20,31H,12-19H2,1-4H3 MQJAAEHAYZQXMY-UHFFFAOYSA-N 345926 N-(2-Dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 1 Atypical chemokine receptor 3 Human 8.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345926&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378963 385451978 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682713 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ncccc1C(F)(F)F InChI=1S/C26H36F3N5O2/c1-19(2)16-33-13-14-36-25-20(17-33)7-5-9-22(25)31-15-24(35)34(12-11-32(3)4)18-23-21(26(27,28)29)8-6-10-30-23/h5-10,19,31H,11-18H2,1-4H3 ZNSKTYZRIMANPD-UHFFFAOYSA-N 345927 N-(2-Dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 2 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345927&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114456 385451979 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682714 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ncccc1Cl InChI=1S/C25H36ClN5O2/c1-19(2)16-30-13-14-33-25-20(17-30)7-5-9-22(25)28-15-24(32)31(12-11-29(3)4)18-23-21(26)8-6-10-27-23/h5-10,19,28H,11-18H2,1-4H3 XUWYMPKPSGJZHI-UHFFFAOYSA-N 345928 N-(3-Chloro-pyridin-2-ylmethyl)-N-(2-dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 3 Atypical chemokine receptor 3 Human 9.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345928&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378956 385451980 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682715 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ncccc1Cl InChI=1S/C23H32ClN5O2/c1-4-28-13-14-31-23-18(16-28)7-5-9-20(23)26-15-22(30)29(12-11-27(2)3)17-21-19(24)8-6-10-25-21/h5-10,26H,4,11-17H2,1-3H3 DGOILCPMMSLCCB-UHFFFAOYSA-N 345929 N-(3-Chloro-pyridin-2-ylmethyl)-N-(2-dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 4 Atypical chemokine receptor 3 Human 24.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345929&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378946 385451981 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682716 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C25H33F3N4O2/c1-4-31-14-15-34-24-20(17-31)9-7-11-22(24)29-16-23(33)32(13-12-30(2)3)18-19-8-5-6-10-21(19)25(26,27)28/h5-11,29H,4,12-18H2,1-3H3 HRZPETMHUTVMNG-UHFFFAOYSA-N 345930 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 5 Atypical chemokine receptor 3 Human 7.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345930&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114672 385451982 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682717 CCCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ncccc1Cl InChI=1S/C24H34ClN5O2/c1-4-11-29-14-15-32-24-19(17-29)7-5-9-21(24)27-16-23(31)30(13-12-28(2)3)18-22-20(25)8-6-10-26-22/h5-10,27H,4,11-18H2,1-3H3 QWILRWZSSDIXAX-UHFFFAOYSA-N 345931 N-(3-Chloro-pyridin-2-ylmethyl)-N-(2-dimethylamino-ethyl)-2-(4-propyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 6 Atypical chemokine receptor 3 Human 19.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345931&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121379007 385451983 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682718 CCCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C26H35F3N4O2/c1-4-12-32-15-16-35-25-21(18-32)9-7-11-23(25)30-17-24(34)33(14-13-31(2)3)19-20-8-5-6-10-22(20)26(27,28)29/h5-11,30H,4,12-19H2,1-3H3 KPORZRGTKKBPQB-UHFFFAOYSA-N 345932 N-(2-Dimethylamino-ethyl)-2-(4-propyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 7 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345932&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378954 385451984 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682719 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1cccc(Br)c1 InChI=1S/C26H37BrN4O2/c1-20(2)17-30-13-14-33-26-22(19-30)8-6-10-24(26)28-16-25(32)31(12-11-29(3)4)18-21-7-5-9-23(27)15-21/h5-10,15,20,28H,11-14,16-19H2,1-4H3 FARAOLZITJAOEU-UHFFFAOYSA-N 345933 N-(3-Bromo-benzyl)-N-(2-dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 8 Atypical chemokine receptor 3 Human 36.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345933&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378927 385451985 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682720 COc1ccnc(CN(CCN(C)C)C(=O)CNc2cccc3CN(CC(C)C)CCOc23)c1 InChI=1S/C26H39N5O3/c1-20(2)17-30-13-14-34-26-21(18-30)7-6-8-24(26)28-16-25(32)31(12-11-29(3)4)19-22-15-23(33-5)9-10-27-22/h6-10,15,20,28H,11-14,16-19H2,1-5H3 OIWCLTJEDJWXNX-UHFFFAOYSA-N 345934 N-(2-Dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(4-methoxy-pyridin-2-ylmethyl)-acetamide::US10202368, Example 9 Atypical chemokine receptor 3 Human 200 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345934&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114488 385451986 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682721 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCNCC1CC1)Cc1ccccc1C(F)(F)F InChI=1S/C29H39F3N4O2/c1-21(2)18-35-14-15-38-28-24(19-35)7-5-9-26(28)34-17-27(37)36(13-12-33-16-22-10-11-22)20-23-6-3-4-8-25(23)29(30,31)32/h3-9,21-22,33-34H,10-20H2,1-2H3 HBKQYGVEPKPQDK-UHFFFAOYSA-N 345935 N-[2-(Cyclopropyl-methyl-amino)-ethyl]-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 10 Atypical chemokine receptor 3 Human 58.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345935&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378960 385451987 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682722 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCCC1=O)Cc1ccccc1C(F)(F)F InChI=1S/C29H37F3N4O3/c1-21(2)18-34-15-16-39-28-23(19-34)8-5-10-25(28)33-17-27(38)36(14-13-35-12-6-11-26(35)37)20-22-7-3-4-9-24(22)29(30,31)32/h3-5,7-10,21,33H,6,11-20H2,1-2H3 RHTJGFMBNHCCSY-UHFFFAOYSA-N 345936 2-(4-Isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-[2-(2-oxo-pyrrolidin-1-yl)-ethyl]-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 11 Atypical chemokine receptor 3 Human 190 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345936&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114553 385451988 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682723 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCCC1)Cc1ccc(F)cc1F InChI=1S/C28H38F2N4O2/c1-21(2)18-33-14-15-36-28-23(19-33)6-5-7-26(28)31-17-27(35)34(13-12-32-10-3-4-11-32)20-22-8-9-24(29)16-25(22)30/h5-9,16,21,31H,3-4,10-15,17-20H2,1-2H3 LEGJURAGEHJGED-UHFFFAOYSA-N 345937 N-(2,4-Difluoro-benzyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide::US10202368, Example 12 Atypical chemokine receptor 3 Human 14.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345937&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114639 385451989 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682724 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCC(F)(F)CC1)Cc1ncccc1Cl InChI=1S/C28H38ClF2N5O2/c1-21(2)18-35-15-16-38-27-22(19-35)5-3-7-24(27)33-17-26(37)36(20-25-23(29)6-4-10-32-25)14-13-34-11-8-28(30,31)9-12-34/h3-7,10,21,33H,8-9,11-20H2,1-2H3 FPAIGRVOXILWRI-UHFFFAOYSA-N 345938 N-(3-Chloro-pyridin-2-ylmethyl)-N-[2-(4,4-difluoro-piperidin-1-yl)-ethyl]-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 13 Atypical chemokine receptor 3 Human 88.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345938&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114445 385451990 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682725 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1cc(C)ccn1 InChI=1S/C26H39N5O2/c1-20(2)17-30-13-14-33-26-22(18-30)7-6-8-24(26)28-16-25(32)31(12-11-29(4)5)19-23-15-21(3)9-10-27-23/h6-10,15,20,28H,11-14,16-19H2,1-5H3 BVAACBDDPKPGGD-UHFFFAOYSA-N 345939 N-(2-Dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(4-methyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 14 Atypical chemokine receptor 3 Human 76.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345939&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114464 385451991 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682726 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCCC1)Cc1ccccc1Cl InChI=1S/C28H39ClN4O2/c1-22(2)19-32-16-17-35-28-24(20-32)9-7-11-26(28)30-18-27(34)33(15-14-31-12-5-6-13-31)21-23-8-3-4-10-25(23)29/h3-4,7-11,22,30H,5-6,12-21H2,1-2H3 FDVBGVXFJFPJGT-UHFFFAOYSA-N 345940 N-(2-Chloro-benzyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide::US10202368, Example 15 Atypical chemokine receptor 3 Human 11.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345940&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114551 385451992 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682727 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCOCC1)Cc1ccccc1C(F)(F)F InChI=1S/C29H39F3N4O3/c1-22(2)19-35-14-17-39-28-24(20-35)7-5-9-26(28)33-18-27(37)36(11-10-34-12-15-38-16-13-34)21-23-6-3-4-8-25(23)29(30,31)32/h3-9,22,33H,10-21H2,1-2H3 AKQRETVBHQXPRK-UHFFFAOYSA-N 345941 2-(4-Isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-morpholin-4-yl-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 16 Atypical chemokine receptor 3 Human 74.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345941&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114477 385451993 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682728 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ccc(F)cc1C(F)(F)F InChI=1S/C27H36F4N4O2/c1-19(2)16-34-12-13-37-26-21(17-34)6-5-7-24(26)32-15-25(36)35(11-10-33(3)4)18-20-8-9-22(28)14-23(20)27(29,30)31/h5-9,14,19,32H,10-13,15-18H2,1-4H3 SYBYBRBHMRPQIW-UHFFFAOYSA-N 345942 N-(2-Dimethylamino-ethyl)-N-(4-fluoro-2-trifluoromethyl-benzyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 17 Atypical chemokine receptor 3 Human 59.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345942&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114632 385451994 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682729 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1cccc(c1)C(F)(F)F InChI=1S/C27H37F3N4O2/c1-20(2)17-33-13-14-36-26-22(19-33)8-6-10-24(26)31-16-25(35)34(12-11-32(3)4)18-21-7-5-9-23(15-21)27(28,29)30/h5-10,15,20,31H,11-14,16-19H2,1-4H3 NBWSECFDRYGLMZ-UHFFFAOYSA-N 345943 N-(2-Dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(3-trifluoromethyl-benzyl)-acetamide::US10202368, Example 18 Atypical chemokine receptor 3 Human 53.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345943&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114644 385451995 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682730 CC(C)CN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1c(F)cccc1F InChI=1S/C26H36F2N4O2/c1-19(2)16-31-13-14-34-26-20(17-31)7-5-10-24(26)29-15-25(33)32(12-11-30(3)4)18-21-22(27)8-6-9-23(21)28/h5-10,19,29H,11-18H2,1-4H3 GMACMDDQXVTETK-UHFFFAOYSA-N 345944 N-(2,6-Difluoro-benzyl)-N-(2-dimethylamino-ethyl)-2-(4-isobutyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 19 Atypical chemokine receptor 3 Human 12.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345944&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378887 385451996 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682731 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CCOc12)C(C)=O InChI=1S/C25H31F3N4O3/c1-18(33)31-13-14-35-24-20(17-31)8-6-10-22(24)29-15-23(34)32(12-11-30(2)3)16-19-7-4-5-9-21(19)25(26,27)28/h4-10,29H,11-17H2,1-3H3 CIYXAYVYNZCSRA-UHFFFAOYSA-N 345945 2-(4-Acetyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 20 Atypical chemokine receptor 3 Human 73.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345945&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114469 385451997 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682732 CCN1CCNc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C25H34F3N5O/c1-4-32-13-12-29-24-20(17-32)9-7-11-22(24)30-16-23(34)33(15-14-31(2)3)18-19-8-5-6-10-21(19)25(26,27)28/h5-11,29-30H,4,12-18H2,1-3H3 OBPAXNIKNGHVCR-UHFFFAOYSA-N 345946 N-(2-(dimethylamino)ethyl)-2-((4-ethyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-yl)amino)-N-(2-(trifluoromethyl)benzyl)acetamide::US10202368, Example 21 Atypical chemokine receptor 3 Human 6.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345946&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121379006 385451998 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682733 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C27H35F3N4O2/c1-32(2)12-13-34(18-21-6-3-4-7-23(21)27(28,29)30)26(35)16-31-24-8-5-9-25-22(24)19-33(14-15-36-25)17-20-10-11-20/h3-9,20,31H,10-19H2,1-2H3 GAOLRXGKORHZND-UHFFFAOYSA-N 345947 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 22 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345947&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378937 385451999 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682734 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)COc1cccc2CCN(CC3CC3)CCc12 InChI=1S/C28H36F3N3O2/c1-32(2)16-17-34(19-23-6-3-4-8-25(23)28(29,30)31)27(35)20-36-26-9-5-7-22-12-14-33(15-13-24(22)26)18-21-10-11-21/h3-9,21H,10-20H2,1-2H3 MCECIBHEXVUWJX-UHFFFAOYSA-N 345948 2-(3-Cyclopropylmethyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-yloxy)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 23 Atypical chemokine receptor 3 Human 1.000 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345948&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114622 385452000 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682735 COCC(=O)N1CCc2cccc(OCC(=O)N(CCN(C)C)Cc3ccccc3C(F)(F)F)c2CC1 InChI=1S/C27H34F3N3O4/c1-31(2)15-16-33(17-21-7-4-5-9-23(21)27(28,29)30)26(35)19-37-24-10-6-8-20-11-13-32(14-12-22(20)24)25(34)18-36-3/h4-10H,11-19H2,1-3H3 ZPHLXZRAJGMDDB-UHFFFAOYSA-N 345949 N-(2-Dimethylamino-ethyl)-2-[3-(2-methoxy-acetyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-yloxy]-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 24 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345949&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114582 385452001 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682736 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)COc1cccc2CCN(CCc12)C(C)=O InChI=1S/C26H32F3N3O3/c1-19(33)31-13-11-20-8-6-10-24(22(20)12-14-31)35-18-25(34)32(16-15-30(2)3)17-21-7-4-5-9-23(21)26(27,28)29/h4-10H,11-18H2,1-3H3 KTJDCTKXKAFNPT-UHFFFAOYSA-N 345950 2-(3-Acetyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-yloxy)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 25 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345950&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114462 385452002 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682737 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CCN(CCc12)C(=O)C(F)(F)F InChI=1S/C26H30F6N4O2/c1-34(2)14-15-36(17-19-6-3-4-8-21(19)25(27,28)29)23(37)16-33-22-9-5-7-18-10-12-35(13-11-20(18)22)24(38)26(30,31)32/h3-9,33H,10-17H2,1-2H3 AWWABAUISCORRC-UHFFFAOYSA-N 345951 N-(2-Dimethylamino-ethyl)-2-[3-(2,2,2-trifluoro-acetyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-ylamino]-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 26 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345951&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114662 385452003 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682738 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CCN(CC3CC3)CCc12 InChI=1S/C28H37F3N4O/c1-33(2)16-17-35(20-23-6-3-4-8-25(23)28(29,30)31)27(36)18-32-26-9-5-7-22-12-14-34(15-13-24(22)26)19-21-10-11-21/h3-9,21,32H,10-20H2,1-2H3 BWRVICYVKDJBAE-UHFFFAOYSA-N 345952 2-(3-Cyclopropylmethyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 27 Atypical chemokine receptor 3 Human 2.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345952&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114472 385452004 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682739 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCCc12 InChI=1S/C28H37F3N4O/c1-33(2)15-16-35(20-23-7-3-4-10-25(23)28(29,30)31)27(36)17-32-26-11-5-8-22-19-34(18-21-12-13-21)14-6-9-24(22)26/h3-5,7-8,10-11,21,32H,6,9,12-20H2,1-2H3 WQSSKXPCBAZMOM-UHFFFAOYSA-N 345953 2-(2-Cyclopropylmethyl-2,3,4,5-tetrahydro-1H-benzo[c]azepin-6-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 28 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345953&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378889 385452005 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682740 CC(C)(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C29H37F3N4O3/c1-28(2,3)34-13-14-35(19-21-7-4-5-8-22(21)29(30,31)32)25(37)17-33-23-9-6-10-24-26(23)27(38)36(15-16-39-24)18-20-11-12-20/h4-10,20,33-34H,11-19H2,1-3H3 NPKZILMNXMEMLY-UHFFFAOYSA-N 345954 N-(2-tert-Butylamino-ethyl)-2-(4-cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 29 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345954&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114614 385452006 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682741 CN(C)CCN(Cc1cccc(Cl)c1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C26H32Cl2N4O3/c1-30(2)11-12-31(17-19-5-3-6-20(27)25(19)28)23(33)15-29-21-7-4-8-22-24(21)26(34)32(13-14-35-22)16-18-9-10-18/h3-8,18,29H,9-17H2,1-2H3 YOFDPQRUCJJNOE-UHFFFAOYSA-N 345955 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2,3-dichloro-benzyl)-N-(2-dimethylamino-ethyl)-acetamide::US10202368, Example 30 Atypical chemokine receptor 3 Human 7.80 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345955&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114466 385452007 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682742 CN(C)CCN(Cc1c(Cl)cccc1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C26H32Cl2N4O3/c1-30(2)11-12-31(17-19-20(27)5-3-6-21(19)28)24(33)15-29-22-7-4-8-23-25(22)26(34)32(13-14-35-23)16-18-9-10-18/h3-8,18,29H,9-17H2,1-2H3 LAPQJPAURYVHON-UHFFFAOYSA-N 345956 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2,6-dichloro-benzyl)-N-(2-dimethylamino-ethyl)-acetamide::US10202368, Example 31 Atypical chemokine receptor 3 Human 27.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345956&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114470 385452008 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682743 CN(C)CCN(Cc1ccccc1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C26H33ClN4O3/c1-29(2)12-13-30(18-20-6-3-4-7-21(20)27)24(32)16-28-22-8-5-9-23-25(22)26(33)31(14-15-34-23)17-19-10-11-19/h3-9,19,28H,10-18H2,1-2H3 XWOLXALTDZJKQE-UHFFFAOYSA-N 345957 N-(2-Chloro-benzyl)-2-(4-cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-dimethylamino-ethyl)-acetamide::US10202368, Example 32 Atypical chemokine receptor 3 Human 15.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345957&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378980 385452009 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682744 CN(C)CCN(Cc1cccc(C)n1)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C26H35N5O3/c1-19-6-4-7-21(28-19)18-30(13-12-29(2)3)24(32)16-27-22-8-5-9-23-25(22)26(33)31(14-15-34-23)17-20-10-11-20/h4-9,20,27H,10-18H2,1-3H3 YQYXCUUAGBYESS-UHFFFAOYSA-N 345958 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-dimethylamino-ethyl)-N-(6-methyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 33 Atypical chemokine receptor 3 Human 24.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345958&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114625 385452010 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682745 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C28H35F3N4O3/c1-19(2)32-12-13-34(18-21-6-3-4-7-22(21)28(29,30)31)25(36)16-33-23-8-5-9-24-26(23)27(37)35(14-15-38-24)17-20-10-11-20/h3-9,19-20,32-33H,10-18H2,1-2H3 VRVUHSHWPOLAIM-UHFFFAOYSA-N 345959 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 34 Atypical chemokine receptor 3 Human 5.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345959&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114489 385452011 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682746 CC(C)N(CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12)C(=O)OC(C)(C)C InChI=1S/C33H43F3N4O5/c1-22(2)40(31(43)45-32(3,4)5)16-15-38(21-24-9-6-7-10-25(24)33(34,35)36)28(41)19-37-26-11-8-12-27-29(26)30(42)39(17-18-44-27)20-23-13-14-23/h6-12,22-23,37H,13-21H2,1-5H3 NVGUJZPUVATOAY-UHFFFAOYSA-N 345960 US10202368, Example 35::{2-[[2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-acetyl]-(2-trifluoromethyl-benzyl)-amino]-ethyl}-isopropyl-carbamic acid tert-butyl ester Atypical chemokine receptor 3 Human 420 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345960&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114609 385452012 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682747 CNCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C26H31F3N4O3/c1-30-11-12-32(17-19-5-2-3-6-20(19)26(27,28)29)23(34)15-31-21-7-4-8-22-24(21)25(35)33(13-14-36-22)16-18-9-10-18/h2-8,18,30-31H,9-17H2,1H3 QUBBDOUQLCTJLE-UHFFFAOYSA-N 345961 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-methylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 36 Atypical chemokine receptor 3 Human 12.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345961&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114753 385452013 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682748 CN(CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12)C(=O)OC(C)(C)C InChI=1S/C31H39F3N4O5/c1-30(2,3)43-29(41)36(4)14-15-37(20-22-8-5-6-9-23(22)31(32,33)34)26(39)18-35-24-10-7-11-25-27(24)28(40)38(16-17-42-25)19-21-12-13-21/h5-11,21,35H,12-20H2,1-4H3 AZVRHWDHSFGAFX-UHFFFAOYSA-N 345962 US10202368, Example 37::{2-[[2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-acetyl]-(2-trifluoromethyl-benzyl)-amino]-ethyl}-methyl-carbamic acid tert-butyl ester Atypical chemokine receptor 3 Human 410 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345962&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114579 385452014 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682749 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)C(=O)c12 InChI=1S/C27H33F3N4O3/c1-32(2)12-13-33(18-20-6-3-4-7-21(20)27(28,29)30)24(35)16-31-22-8-5-9-23-25(22)26(36)34(14-15-37-23)17-19-10-11-19/h3-9,19,31H,10-18H2,1-2H3 PXWYCZYVDOMKNQ-UHFFFAOYSA-N 345963 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 38 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345963&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114759 385452015 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682750 CCN1CCOc2c(NCC(=O)N(CCN(C)C)Cc3ncccc3C)cccc2C1=O InChI=1S/C24H33N5O3/c1-5-28-14-15-32-23-19(24(28)31)9-6-10-20(23)26-16-22(30)29(13-12-27(3)4)17-21-18(2)8-7-11-25-21/h6-11,26H,5,12-17H2,1-4H3 PSFMBLPPTBZYPQ-UHFFFAOYSA-N 345964 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(3-methyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 39 Atypical chemokine receptor 3 Human 400 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345964&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114676 385452016 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682751 CCN1CCOc2c(NCC(=O)N(CCNC(C)(C)C)Cc3ccccc3C(F)(F)F)cccc2C1=O InChI=1S/C27H35F3N4O3/c1-5-33-15-16-37-24-20(25(33)36)10-8-12-22(24)31-17-23(35)34(14-13-32-26(2,3)4)18-19-9-6-7-11-21(19)27(28,29)30/h6-12,31-32H,5,13-18H2,1-4H3 XZIKARMHJUUAHB-UHFFFAOYSA-N 345965 N-(2-tert-Butylamino-ethyl)-2-(4-ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 40 Atypical chemokine receptor 3 Human 7.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345965&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114452 385452017 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682752 CCN1CCOc2c(NCC(=O)N(CCN(C)C)Cc3ccccc3C(F)(F)F)cccc2C1=O InChI=1S/C25H31F3N4O3/c1-4-31-14-15-35-23-19(24(31)34)9-7-11-21(23)29-16-22(33)32(13-12-30(2)3)17-18-8-5-6-10-20(18)25(26,27)28/h5-11,29H,4,12-17H2,1-3H3 TZTBRQMHKBYXHK-UHFFFAOYSA-N 345966 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 41 Atypical chemokine receptor 3 Human 22.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345966&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121379017 385452018 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682753 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2c1N(C)CCN(CC1CC1)C2=O InChI=1S/C28H36F3N5O2/c1-33(2)13-15-35(19-21-7-4-5-9-23(21)28(29,30)31)25(37)17-32-24-10-6-8-22-26(24)34(3)14-16-36(27(22)38)18-20-11-12-20/h4-10,20,32H,11-19H2,1-3H3 QSCVJJMCUYIDCZ-UHFFFAOYSA-N 345967 2-(4-Cyclopropylmethyl-1-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 42 Atypical chemokine receptor 3 Human 7.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345967&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378911 385452019 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682754 CN1CCN(CC2CC2)C(=O)c2cccc(NCC(=O)N(CCNC(C)(C)C)Cc3ccccc3C(F)(F)F)c12 InChI=1S/C30H40F3N5O2/c1-29(2,3)35-14-15-37(20-22-8-5-6-10-24(22)30(31,32)33)26(39)18-34-25-11-7-9-23-27(25)36(4)16-17-38(28(23)40)19-21-12-13-21/h5-11,21,34-35H,12-20H2,1-4H3 DNUCGAXXCQAXPI-UHFFFAOYSA-N 345968 N-(2-tert-Butylamino-ethyl)-2-(4-cyclopropylmethyl-1-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 43 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345968&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378922 385452020 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682755 CN(C)CCN(Cc1ncccc1C)C(=O)CNc1cccc2c1N(C)CCN(CC1CC1)C2=O InChI=1S/C27H38N6O2/c1-20-7-6-12-28-24(20)19-32(15-13-30(2)3)25(34)17-29-23-9-5-8-22-26(23)31(4)14-16-33(27(22)35)18-21-10-11-21/h5-9,12,21,29H,10-11,13-19H2,1-4H3 QLVVFBJSPRWUGD-UHFFFAOYSA-N 345969 2-(4-Cyclopropylmethyl-1-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(3-methyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 44 Atypical chemokine receptor 3 Human 130 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345969&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378941 385452021 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682756 CN(C)CCN(Cc1ncccc1Cl)C(=O)CNc1cccc2c1N(C)CCN(CC1CC1)C2=O InChI=1S/C26H35ClN6O2/c1-30(2)12-14-32(18-23-21(27)7-5-11-28-23)24(34)16-29-22-8-4-6-20-25(22)31(3)13-15-33(26(20)35)17-19-9-10-19/h4-8,11,19,29H,9-10,12-18H2,1-3H3 PTTBBRDGHQHDMQ-UHFFFAOYSA-N 345970 N-(3-Chloro-pyridin-2-ylmethyl)-2-(4-cyclopropylmethyl-1-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-acetamide::US10202368, Example 45 Atypical chemokine receptor 3 Human 50.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345970&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378902 385452022 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682757 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2c1N(C)CCN(CC1CC1)C2=O InChI=1S/C29H38F3N5O2/c1-20(2)33-13-14-36(19-22-7-4-5-9-24(22)29(30,31)32)26(38)17-34-25-10-6-8-23-27(25)35(3)15-16-37(28(23)39)18-21-11-12-21/h4-10,20-21,33-34H,11-19H2,1-3H3 YWVCOMBTTZXYSM-UHFFFAOYSA-N 345971 2-(4-Cyclopropylmethyl-1-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 46 Atypical chemokine receptor 3 Human 5.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345971&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378876 385452023 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682758 CCN1CCN(CC)C(=O)c2cccc(NCC(=O)N(CCN3CCOCC3)Cc3ncccc3C(F)(F)F)c12 InChI=1S/C28H37F3N6O3/c1-3-35-13-14-36(4-2)27(39)21-7-5-9-23(26(21)35)33-19-25(38)37(12-11-34-15-17-40-18-16-34)20-24-22(28(29,30)31)8-6-10-32-24/h5-10,33H,3-4,11-20H2,1-2H3 BVQPSNRNLHFLSO-UHFFFAOYSA-N 345972 2-(1,4-Diethyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-morpholin-4-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 47 Atypical chemokine receptor 3 Human 430 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345972&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378933 385452024 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682759 CCN1CCN(CC)C(=O)c2cccc(NCC(=O)N(CCN3CCCC3)Cc3ncccc3C(F)(F)F)c12 InChI=1S/C28H37F3N6O2/c1-3-35-17-18-36(4-2)27(39)21-9-7-11-23(26(21)35)33-19-25(38)37(16-15-34-13-5-6-14-34)20-24-22(28(29,30)31)10-8-12-32-24/h7-12,33H,3-6,13-20H2,1-2H3 CXIBZBKHWZSKLU-UHFFFAOYSA-N 345973 2-(1,4-Diethyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 48 Atypical chemokine receptor 3 Human 47.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345973&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378874 385452025 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682760 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCN(C)c12 InChI=1S/C28H38F3N5O/c1-33(2)13-16-36(20-22-7-4-5-9-24(22)28(29,30)31)26(37)17-32-25-10-6-8-23-19-35(18-21-11-12-21)15-14-34(3)27(23)25/h4-10,21,32H,11-20H2,1-3H3 WZVZHFQCNXKJLC-UHFFFAOYSA-N 345974 2-(4-Cyclopropylmethyl-1-methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 49 Atypical chemokine receptor 3 Human 2.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345974&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378929 385452026 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682761 CC(C)N(CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCN(C)c12)C(=O)OC(C)(C)C InChI=1S/C34H48F3N5O3/c1-24(2)42(32(44)45-33(3,4)5)19-18-41(23-26-10-7-8-12-28(26)34(35,36)37)30(43)20-38-29-13-9-11-27-22-40(21-25-14-15-25)17-16-39(6)31(27)29/h7-13,24-25,38H,14-23H2,1-6H3 ZURDGFLTQCAXON-UHFFFAOYSA-N 345975 US10202368, Example 50::{2-[[2-(4-Cyclopropylmethyl-1-methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-acetyl]-(2-trifluoromethyl-benzyl)-amino]-ethyl}-isopropyl-carbamic acid tert-butyl ester Atypical chemokine receptor 3 Human 340 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345975&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378968 385452027 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682762 CN1CCN(CC2CC2)Cc2cccc(NCC(=O)N(CCN3CCCC3)Cc3ncccc3C(F)(F)F)c12 InChI=1S/C29H39F3N6O/c1-35-14-15-37(19-22-9-10-22)20-23-6-4-8-25(28(23)35)34-18-27(39)38(17-16-36-12-2-3-13-36)21-26-24(29(30,31)32)7-5-11-33-26/h4-8,11,22,34H,2-3,9-10,12-21H2,1H3 CBWRTXJXLIRXEO-UHFFFAOYSA-N 345976 2-(4-Cyclopropylmethyl-1-methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 51 Atypical chemokine receptor 3 Human 1.000 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345976&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114473 385452028 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682763 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCN(C)c12 InChI=1S/C29H40F3N5O/c1-21(2)33-13-14-37(20-23-7-4-5-9-25(23)29(30,31)32)27(38)17-34-26-10-6-8-24-19-36(18-22-11-12-22)16-15-35(3)28(24)26/h4-10,21-22,33-34H,11-20H2,1-3H3 WUNVPJRBTOYSPT-UHFFFAOYSA-N 345977 2-(4-Cyclopropylmethyl-1-methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 52 Atypical chemokine receptor 3 Human 1.000 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345977&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114750 385452029 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682764 CN1CCN(CC2CC2)Cc2cccc(NCC(=O)N(CCN3CCOCC3)Cc3ncccc3C(F)(F)F)c12 InChI=1S/C29H39F3N6O2/c1-35-10-11-37(19-22-7-8-22)20-23-4-2-6-25(28(23)35)34-18-27(39)38(13-12-36-14-16-40-17-15-36)21-26-24(29(30,31)32)5-3-9-33-26/h2-6,9,22,34H,7-8,10-21H2,1H3 HSSKUXMENSYPFX-UHFFFAOYSA-N 345978 2-(4-Cyclopropylmethyl-1-methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-9-ylamino)-N-(2-morpholin-4-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 55 Atypical chemokine receptor 3 Human 10.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345978&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114555 385452030 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682765 CCN1CCOc2c(NCC(=O)N(CCNC(C)C)Cc3ccccc3C(F)(F)F)cccc2C1=O InChI=1S/C26H33F3N4O3/c1-4-32-14-15-36-24-20(25(32)35)9-7-11-22(24)31-16-23(34)33(13-12-30-18(2)3)17-19-8-5-6-10-21(19)26(27,28)29/h5-11,18,30-31H,4,12-17H2,1-3H3 GHXOXYIKSYPBPC-UHFFFAOYSA-N 345979 2-(4-Ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 56 Atypical chemokine receptor 3 Human 16.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345979&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378977 385452031 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682766 CCN1CCOc2c(NCC(=O)N(CCN3CCCC3)Cc3ncccc3C(F)(F)F)cccc2C1=O InChI=1S/C26H32F3N5O3/c1-2-33-15-16-37-24-19(25(33)36)7-5-9-21(24)31-17-23(35)34(14-13-32-11-3-4-12-32)18-22-20(26(27,28)29)8-6-10-30-22/h5-10,31H,2-4,11-18H2,1H3 YTQVLTCZGPIOFM-UHFFFAOYSA-N 345980 2-(4-Ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 57 Atypical chemokine receptor 3 Human 60.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345980&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114627 385452032 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682767 CCN1CCOc2c(NCC(=O)N(CCN(C)C)Cc3ncccc3C(F)(F)F)cccc2C1=O InChI=1S/C24H30F3N5O3/c1-4-31-13-14-35-22-17(23(31)34)7-5-9-19(22)29-15-21(33)32(12-11-30(2)3)16-20-18(24(25,26)27)8-6-10-28-20/h5-10,29H,4,11-16H2,1-3H3 MSJMLUZWQSRYIE-UHFFFAOYSA-N 345981 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 58 Atypical chemokine receptor 3 Human 74.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345981&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114594 385452033 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682768 CCN1CCOc2c(NCC(=O)N(CCN3CCCC3)Cc3ncccc3Cl)cccc2C1=O InChI=1S/C25H32ClN5O3/c1-2-30-15-16-34-24-19(25(30)33)7-5-9-21(24)28-17-23(32)31(14-13-29-11-3-4-12-29)18-22-20(26)8-6-10-27-22/h5-10,28H,2-4,11-18H2,1H3 FTYOOMVWYLCXHJ-UHFFFAOYSA-N 345982 N-(3-Chloro-pyridin-2-ylmethyl)-2-(4-ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide::US10202368, Example 59 Atypical chemokine receptor 3 Human 260 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345982&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114612 385452034 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682769 CCN1CCOc2c(NCC(=O)N(CCN(C)C)Cc3ncccc3Cl)cccc2C1=O InChI=1S/C23H30ClN5O3/c1-4-28-13-14-32-22-17(23(28)31)7-5-9-19(22)26-15-21(30)29(12-11-27(2)3)16-20-18(24)8-6-10-25-20/h5-10,26H,4,11-16H2,1-3H3 AFAHGLBBPMLIAH-UHFFFAOYSA-N 345983 N-(3-Chloro-pyridin-2-ylmethyl)-N-(2-dimethylamino-ethyl)-2-(4-ethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 60 Atypical chemokine receptor 3 Human 260 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345983&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114455 385452035 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682770 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2c1OCCN(CC1CC1)C2=O InChI=1S/C27H33F3N4O3/c1-32(2)12-13-33(18-20-6-3-4-8-22(20)27(28,29)30)24(35)16-31-23-9-5-7-21-25(23)37-15-14-34(26(21)36)17-19-10-11-19/h3-9,19,31H,10-18H2,1-2H3 INDVTNBAVAMXEG-UHFFFAOYSA-N 345984 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 61 Atypical chemokine receptor 3 Human 9.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345984&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378898 385452036 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682771 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2c1OCCN(CC1CC1)C2=O InChI=1S/C28H35F3N4O3/c1-19(2)32-12-13-34(18-21-6-3-4-8-23(21)28(29,30)31)25(36)16-33-24-9-5-7-22-26(24)38-15-14-35(27(22)37)17-20-10-11-20/h3-9,19-20,32-33H,10-18H2,1-2H3 OLHAMCIMZGQDBA-UHFFFAOYSA-N 345985 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 62 Atypical chemokine receptor 3 Human 5.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345985&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378908 385452037 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682772 CC(C)(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2c1OCCN(CC1CC1)C2=O InChI=1S/C29H37F3N4O3/c1-28(2,3)34-13-14-35(19-21-7-4-5-9-23(21)29(30,31)32)25(37)17-33-24-10-6-8-22-26(24)39-16-15-36(27(22)38)18-20-11-12-20/h4-10,20,33-34H,11-19H2,1-3H3 GNPMTWIUXLGWJB-UHFFFAOYSA-N 345986 N-(2-tert-Butylamino-ethyl)-2-(4-cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 63 Atypical chemokine receptor 3 Human 2.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345986&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378907 385452038 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682773 FC(F)(F)c1cccnc1CN(CCN1CCCC1)C(=O)CNc1cccc2c1OCCN(CC1CC1)C2=O InChI=1S/C28H34F3N5O3/c29-28(30,31)22-6-4-10-32-24(22)19-35(14-13-34-11-1-2-12-34)25(37)17-33-23-7-3-5-21-26(23)39-16-15-36(27(21)38)18-20-8-9-20/h3-7,10,20,33H,1-2,8-9,11-19H2 OKLATCFZGMMKBL-UHFFFAOYSA-N 345987 2-(4-Cyclopropylmethyl-5-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 64 Atypical chemokine receptor 3 Human 7.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345987&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114765 385452039 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682774 FC(F)(F)c1cccnc1CN(CCN1CCCC1)C(=O)CNc1cccc2CN(CC3CC3)C(=O)COc12 InChI=1S/C28H34F3N5O3/c29-28(30,31)22-6-4-10-32-24(22)18-35(14-13-34-11-1-2-12-34)25(37)15-33-23-7-3-5-21-17-36(16-20-8-9-20)26(38)19-39-27(21)23/h3-7,10,20,33H,1-2,8-9,11-19H2 PZKCCTTWWBVJPA-UHFFFAOYSA-N 345988 2-(4-cyclopropylmethyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 65 Atypical chemokine receptor 3 Human 18.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345988&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378881 385452040 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682775 CC(C)(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)C(=O)COc12 InChI=1S/C29H37F3N4O3/c1-28(2,3)34-13-14-35(17-21-7-4-5-9-23(21)29(30,31)32)25(37)15-33-24-10-6-8-22-18-36(16-20-11-12-20)26(38)19-39-27(22)24/h4-10,20,33-34H,11-19H2,1-3H3 XDAPPHVGFWJJNY-UHFFFAOYSA-N 345989 N-(2-tert-butylamino-ethyl)-2-(4-cyclopropylmethyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 66 Atypical chemokine receptor 3 Human 18.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345989&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121379008 385452041 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682776 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)C(=O)COc12 InChI=1S/C27H33F3N4O3/c1-32(2)12-13-33(16-20-6-3-4-8-22(20)27(28,29)30)24(35)14-31-23-9-5-7-21-17-34(15-19-10-11-19)25(36)18-37-26(21)23/h3-9,19,31H,10-18H2,1-2H3 GWBVYEHEFFWLTJ-UHFFFAOYSA-N 345990 2-(4-Cyclopropylmethyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 67 Atypical chemokine receptor 3 Human 37.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345990&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378880 385452042 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682777 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)C(=O)COc12 InChI=1S/C28H35F3N4O3/c1-19(2)32-12-13-34(16-21-6-3-4-8-23(21)28(29,30)31)25(36)14-33-24-9-5-7-22-17-35(15-20-10-11-20)26(37)18-38-27(22)24/h3-9,19-20,32-33H,10-18H2,1-2H3 KJQWNMUIFWPWFV-UHFFFAOYSA-N 345991 2-(4-Cyclopropylmethyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 68 Atypical chemokine receptor 3 Human 15.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345991&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378869 385452043 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682778 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C(C)C)C(=O)OC(C)(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C31H43F3N4O4/c1-7-36-17-18-41-28-24(20-36)12-10-14-26(28)35-19-27(39)37(21-23-11-8-9-13-25(23)31(32,33)34)15-16-38(22(2)3)29(40)42-30(4,5)6/h8-14,22,35H,7,15-21H2,1-6H3 VHLUIUICOWKUDK-UHFFFAOYSA-N 345992 US10202368, Example 69::{2-[[2-(4-Ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetyl]-(2-trifluoromethyl-benzyl)-amino]-ethyl}-isopropyl-carbamic acid tert-butyl ester Atypical chemokine receptor 3 Human 430 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345992&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114681 385452044 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682779 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCNC(C)(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C27H37F3N4O2/c1-5-33-15-16-36-25-21(18-33)10-8-12-23(25)31-17-24(35)34(14-13-32-26(2,3)4)19-20-9-6-7-11-22(20)27(28,29)30/h6-12,31-32H,5,13-19H2,1-4H3 SAQSBXUPRTYFBX-UHFFFAOYSA-N 345993 N-(2-tert-Butylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 70 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345993&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114461 385452045 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682780 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCNC(C)C)Cc1ccccc1C(F)(F)F InChI=1S/C26H35F3N4O2/c1-4-32-14-15-35-25-21(17-32)9-7-11-23(25)31-16-24(34)33(13-12-30-19(2)3)18-20-8-5-6-10-22(20)26(27,28)29/h5-11,19,30-31H,4,12-18H2,1-3H3 AQUQERPDFOOGJJ-UHFFFAOYSA-N 345994 2-(4-Ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 71 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345994&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378996 385452046 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682781 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ncccc1C(F)(F)F InChI=1S/C24H32F3N5O2/c1-4-31-13-14-34-23-18(16-31)7-5-9-20(23)29-15-22(33)32(12-11-30(2)3)17-21-19(24(25,26)27)8-6-10-28-21/h5-10,29H,4,11-17H2,1-3H3 UNLYYDAKOVWVOW-UHFFFAOYSA-N 345995 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 72 Atypical chemokine receptor 3 Human 6.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345995&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114787 385452047 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682782 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1ncccc1C InChI=1S/C24H35N5O2/c1-5-28-14-15-31-24-20(17-28)9-6-10-21(24)26-16-23(30)29(13-12-27(3)4)18-22-19(2)8-7-11-25-22/h6-11,26H,5,12-18H2,1-4H3 RJYHBGJJXHLPAO-UHFFFAOYSA-N 345996 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(3-methyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 73 Atypical chemokine receptor 3 Human 59.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345996&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114486 385452048 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682783 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCCC1)Cc1ncccc1C(F)(F)F InChI=1S/C26H34F3N5O2/c1-2-32-15-16-36-25-20(18-32)7-5-9-22(25)31-17-24(35)34(14-13-33-11-3-4-12-33)19-23-21(26(27,28)29)8-6-10-30-23/h5-10,31H,2-4,11-19H2,1H3 KVNAVISKQHQSMZ-UHFFFAOYSA-N 345997 2-(4-Ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 74 Atypical chemokine receptor 3 Human 5.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345997&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114468 385452049 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682784 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN1CCCC1)Cc1ncccc1Cl InChI=1S/C25H34ClN5O2/c1-2-29-15-16-33-25-20(18-29)7-5-9-22(25)28-17-24(32)31(14-13-30-11-3-4-12-30)19-23-21(26)8-6-10-27-23/h5-10,28H,2-4,11-19H2,1H3 QFZNERXEGHXSHA-UHFFFAOYSA-N 345998 N-(3-Chloro-pyridin-2-ylmethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide::US10202368, Example 75 Atypical chemokine receptor 3 Human 19.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345998&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114755 385452050 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682785 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1cnc(s1)C(F)(F)F InChI=1S/C22H30F3N5O2S/c1-4-29-10-11-32-20-16(14-29)6-5-7-18(20)26-13-19(31)30(9-8-28(2)3)15-17-12-27-21(33-17)22(23,24)25/h5-7,12,26H,4,8-11,13-15H2,1-3H3 SHUAXPOVHCEWNS-UHFFFAOYSA-N 345999 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-thiazol-5-ylmethyl)-acetamide::US10202368, Example 76 Atypical chemokine receptor 3 Human 430 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345999&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114481 385452051 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682786 CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)C(C)c1c(Cl)[nH]nc1C(F)(F)F 346000 N-(5-Chloro-1-methyl-3-trifluoromethyl-1H-pyrazol-4-ylmethyl)-N-(2-dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-acetamide::US10202368, Example 77 Atypical chemokine receptor 3 Human 280 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346000&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114585 385452052 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682788 FC(F)(F)c1cccnc1CN(CCN1CCCC1)C(=O)CNc1cccc2CN(CC3CC3)CCOc12 InChI=1S/C28H36F3N5O2/c29-28(30,31)23-6-4-10-32-25(23)20-36(14-13-34-11-1-2-12-34)26(37)17-33-24-7-3-5-22-19-35(18-21-8-9-21)15-16-38-27(22)24/h3-7,10,21,33H,1-2,8-9,11-20H2 OFAKTSFDYATCNI-UHFFFAOYSA-N 346001 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-pyrrolidin-1-yl-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 82 Atypical chemokine receptor 3 Human 2.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346001&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121379005 385452053 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682789 CC(C)(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCOc12 InChI=1S/C29H39F3N4O2/c1-28(2,3)34-13-14-36(20-22-7-4-5-9-24(22)29(30,31)32)26(37)17-33-25-10-6-8-23-19-35(18-21-11-12-21)15-16-38-27(23)25/h4-10,21,33-34H,11-20H2,1-3H3 HBAWQHBIXJJGKR-UHFFFAOYSA-N 346002 N-(2-tert-Butylamino-ethyl)-2-(4-cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 83 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346002&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114645 385452054 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682790 CN(C)CCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCOc12 InChI=1S/C27H35F3N4O2/c1-32(2)12-13-34(19-21-6-3-4-8-23(21)27(28,29)30)25(35)16-31-24-9-5-7-22-18-33(17-20-10-11-20)14-15-36-26(22)24/h3-9,20,31H,10-19H2,1-2H3 GUXNSDYJUKFIFJ-UHFFFAOYSA-N 346003 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-dimethylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 84 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346003&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114757 385452055 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682791 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2CN(CC3CC3)CCOc12 InChI=1S/C28H37F3N4O2/c1-20(2)32-12-13-35(19-22-6-3-4-8-24(22)28(29,30)31)26(36)16-33-25-9-5-7-23-18-34(17-21-10-11-21)14-15-37-27(23)25/h3-9,20-21,32-33H,10-19H2,1-2H3 LQOCCCDPNLUYEP-UHFFFAOYSA-N 346004 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 85 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346004&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378885 385452056 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682792 CN(C)CCN(Cc1ccccc1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C26H35ClN4O2/c1-29(2)12-13-31(18-21-6-3-4-7-23(21)27)26(32)16-28-24-8-5-9-25-22(24)19-30(14-15-33-25)17-20-10-11-20/h3-9,20,28H,10-19H2,1-2H3 DBOJZYPKIGSZLM-UHFFFAOYSA-N 346005 N-(2-Chloro-benzyl)-2-(4-cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-dimethylamino-ethyl)-acetamide::US10202368, Example 86 Atypical chemokine receptor 3 Human 14.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346005&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378890 385452057 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682793 CN(C)CCN(Cc1ncccc1C)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C26H37N5O2/c1-20-6-5-11-27-24(20)19-31(13-12-29(2)3)26(32)16-28-23-7-4-8-25-22(23)18-30(14-15-33-25)17-21-9-10-21/h4-8,11,21,28H,9-10,12-19H2,1-3H3 LUMQPVLIAHSABR-UHFFFAOYSA-N 346006 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-dimethylamino-ethyl)-N-(3-methyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 87 Atypical chemokine receptor 3 Human 23.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346006&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114516 385452058 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682794 CN(C)CCN(Cc1cccc(Cl)c1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C26H34Cl2N4O2/c1-30(2)11-12-32(17-20-5-3-6-22(27)26(20)28)25(33)15-29-23-7-4-8-24-21(23)18-31(13-14-34-24)16-19-9-10-19/h3-8,19,29H,9-18H2,1-2H3 VWTUIQHFRBMHEE-UHFFFAOYSA-N 346007 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2,3-dichloro-benzyl)-N-(2-dimethylamino-ethyl)-acetamide::US10202368, Example 88 Atypical chemokine receptor 3 Human 15.0 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346007&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114463 385452059 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682795 CC(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C28H37F3N4O2/c1-20(2)32-12-13-35(18-22-6-3-4-7-24(22)28(29,30)31)27(36)16-33-25-8-5-9-26-23(25)19-34(14-15-37-26)17-21-10-11-21/h3-9,20-21,32-33H,10-19H2,1-2H3 VLUSWKGYIKNKTI-UHFFFAOYSA-N 346008 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-isopropylamino-ethyl)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 89 Atypical chemokine receptor 3 Human 5.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346008&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378884 385452060 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682796 CC(C)NCCN(Cc1ncccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C27H36F3N5O2/c1-19(2)31-11-12-35(18-24-22(27(28,29)30)5-4-10-32-24)26(36)15-33-23-6-3-7-25-21(23)17-34(13-14-37-25)16-20-8-9-20/h3-7,10,19-20,31,33H,8-9,11-18H2,1-2H3 WJGRAJWAQVNVGA-UHFFFAOYSA-N 346009 2-(4-Cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-isopropylamino-ethyl)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 90 Atypical chemokine receptor 3 Human 7.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346009&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121378953 385452061 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682797 CC(C)(C)NCCN(Cc1ccccc1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C28H39ClN4O2/c1-28(2,3)31-13-14-33(19-22-7-4-5-8-24(22)29)27(34)17-30-25-9-6-10-26-23(25)20-32(15-16-35-26)18-21-11-12-21/h4-10,21,30-31H,11-20H2,1-3H3 OZWYQCZHNCBYMJ-UHFFFAOYSA-N 346010 N-(2-tert-Butylamino-ethyl)-N-(2-chloro-benzyl)-2-(4-cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-acetamide::US10202368, Example 91 Atypical chemokine receptor 3 Human 8.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346010&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114637 385452062 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682798 CC(C)(C)NCCN(Cc1ncccc1Cl)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C27H38ClN5O2/c1-27(2,3)31-12-13-33(19-24-22(28)6-5-11-29-24)26(34)16-30-23-7-4-8-25-21(23)18-32(14-15-35-25)17-20-9-10-20/h4-8,11,20,30-31H,9-10,12-19H2,1-3H3 XIULNZKTIAGVQW-UHFFFAOYSA-N 346011 N-(2-tert-Butylamino-ethyl)-N-(3-chloro-pyridin-2-ylmethyl)-2-(4-cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-acetamide::US10202368, Example 92 Atypical chemokine receptor 3 Human 10.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346011&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114492 385452063 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682799 CC(C)(C)NCCN(Cc1ccccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C29H39F3N4O2/c1-28(2,3)34-13-14-36(19-22-7-4-5-8-24(22)29(30,31)32)27(37)17-33-25-9-6-10-26-23(25)20-35(15-16-38-26)18-21-11-12-21/h4-10,21,33-34H,11-20H2,1-3H3 FPNUWIVIOGICPV-UHFFFAOYSA-N 346012 N-(2-tert-Butylamino-ethyl)-2-(4-cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(2-trifluoromethyl-benzyl)-acetamide::US10202368, Example 93 Atypical chemokine receptor 3 Human 3.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346012&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 132114485 385452064 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986 682800 CC(C)(C)NCCN(Cc1ncccc1C(F)(F)F)C(=O)CNc1cccc2OCCN(CC3CC3)Cc12 InChI=1S/C28H38F3N5O2/c1-27(2,3)34-12-13-36(19-24-22(28(29,30)31)6-5-11-32-24)26(37)16-33-23-7-4-8-25-21(23)18-35(14-15-38-25)17-20-9-10-20/h4-8,11,20,33-34H,9-10,12-19H2,1-3H3 XZMBSONNKFOJDR-UHFFFAOYSA-N 346013 N-(2-tert-Butylamino-ethyl)-2-(4-cyclopropylmethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-6-ylamino)-N-(3-trifluoromethyl-pyridin-2-ylmethyl)-acetamide::US10202368, Example 94 Atypical chemokine receptor 3 Human 4.00 US Patent 10.7270/Q2ZK5JRJ aid1797298 US10202368 Guerry, P; Lehembre, F; Pothier, J; Siendt, H 2/12/2019 9/2/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=346013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10694&target=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=346013&enzyme=Atypical+chemokine+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 121379016 385452065 1 MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK 7SK3,7SK4,7SK5,7SK6,7SK7,7SK8,7SK9 Atypical chemokine receptor 3 ACKR3_HUMAN P25106 A8K6J4 Q53RV4 Q8NE10 Q92938 Q92986